GlassScriptPhysician profile
Mccall Guyton Mcdaniel
NPI 1760706782
$591.88
in general payments reported to CMS, 2019-2025
10 companies · $35.10 in 2025
The $35.10 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.17 · 2020: $15.57 · 2021: $140 · 2022: $48.06 · 2023: $119 · 2024: $145 · 2025: $35.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $251.76 | 2021-2025 | Cd Horizon Spinal System, Unid_pass |
| Depuy Synthes Sales INC. | $87.55 | 2023 | Na |
| Ferring Pharmaceuticals INC. | $64.06 | 2022-2023 | Euflexxa |
| Stryker Corporation | $59.16 | 2019 | |
| Globus Medical, INC. | $50.10 | 2024 | Mini Fragment System |
| Pacira Pharmaceuticals Incorporated | $17.87 | 2024 | Exparel |
| Pacira Therapeutics, INC. | $16.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.80 | 2022 | |
| Ethicon US, LLC | $15.57 | 2020 | |
| Smith+Nephew, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mccall Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.